By Daniel W. Todd, MD
Qnasl is a powdered form of beclomethasone dipropionate, a corticosteroid. ENT allergists consider these drugs to be a first-line treatment for people with allergic rhinitis, which causes a runny nose, sneezing, and watery eyes for allergy sufferers.
Liquid forms of this and other intranasal corticosteroids have been available for years. But many patients don’t like them.
With the corticosteroid nasal sprays, it’s important for patients to use them consistently, but some people don’t like the drip down the back of the nose, the feeling of moisture. They are reluctant to use currently available sprays.
Now they have another option. Qnasl is approved for the treatment of seasonal and year-long allergies in adults and in adolescents aged 12 and older. This is much like the old “Becanase” so many of my patients have been missing.
Posted on September 16, 2012